Can't Miss Webinar—Lupus Nephritis: The ACR Guideline in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Lupus Nephritis
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • Technology
      • Information Technology
      • Apps
    • QA/QI
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
      • Education & Training
    • Certification
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

FDA Approves Obinutuzumab for Lupus Nephritis

Michele B. Kaufman, PharmD, BCGP  |  January 13, 2026

Based on data from multiple clinical trials, the FDA has approved obinutuzumab for the treatment of adults with lupus nephritis in combination with standard therapy.

Dr. Samantha Shapiro, six months post-op: Sunrise at Annapurna Base Camp, Nepal.

Hip Replacements at 14,000 Feet: A Joint Doctor with Joint Disease, Part 2

Samantha C. Shapiro, MD  |  January 13, 2026

Dr. Sam Shapiro writes about her recovery from total hip arthroplasty, detailing what “recovering well with no post-operative complications” really meant and her experience hiking in the Himalayas with a new hip.

Clinical Manifestations of VEXAS

Arthritis & Rheumatology  |  January 13, 2026

Anderson et al. studied genetic data on more than 190,000 participants and found 23 who had genetic variants in the UBA1 gene, which is associated with VEXAS.

Rheumatology Influencers: Dr. Baca Champions Wellness for Both Patients & Physicians

Linda Childers  |  January 12, 2026

As it becomes increasingly difficult for private practice physicians to remain independent & physicians are burning out, Shawn Baca, MD, FACR, is working tirelessly to change healthcare policy.

ACR Image Competition 2025 Results, Part 2—People’s Choice & South Asia Regional Winner

Sarath Chandra Mouli Veeravalli, MD, MRCP (UK)  |  January 12, 2026

Every year, the ACR conducts a case-based image competition. Images are submitted for peer review. The winning images are displayed at ACR Convergence, and winners receive other benefits as well. In October 2025, annual meeting attendees voted on their favorite presentation, selecting the image case from South Asia, presented by Sarath Chandra Mouli Veeravalli, and…

How to Manage Patients with Chronic Low Back Pain

Lara C. Pullen, PhD  |  January 12, 2026

Because back pain is a chronic condition for many patients, rheumatologists should increase their understanding of the common problems of the lumbar spine.

Study Supports Ultrasound Aortic Monitoring in Giant Cell Arteritis

Katie Robinson  |  January 12, 2026

A study identifies ultrasound as a safe, accessible & cost-effective alternative for longitudinal aortic surveillance in patients with GCA.

Dr. Bryce Binstadt Takes Rheumatology Research Foundation’s Reins

Leslie Mertz, PhD  |  January 12, 2026

The Foundation’s new president shares his vision for research funding, fellowship training & securing the future of the rheumatology workforce pipeline.

Rheuminations: Confessions of a Former Pepsi Addict

Bharat Kumar, MD, MME, FACP, FAAAAI, RhMSUS  |  January 11, 2026

Explore a rheumatologist’s journey to break a soda habit & how it reshaped his clinical approach to patient counseling, craving & the psychology of change.

Study Finds Baricitinib Is Effective in Patients with Takayasu Arteritis

Katie Robinson  |  January 10, 2026

A small study shows baricitinib effectively treats refractory Takayasu arteritis & allows for glucocorticoid reduction with no serious adverse events recorded.

  • 1
  • 2
  • 3
  • …
  • 843
  • Next Page »
  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2026 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences